Effect of Vitamin B addition to Lidocaine for Myofascial Trigger Point Injection in Neck and Upper Back Muscles
- Conditions
- Myofascial pain syndromeVitamin B
- Registration Number
- TCTR20190308005
- Lead Sponsor
- Thammasat University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 58
1. The patients with diagnosis as myofascial pain syndrome at neck and upper back by Travel and Simon criteria
2. The symptom persist not more than 6 months
3. 18-70 years old patients
1. The patients who had been treated with Trigger point injection or dry needling at neck and upper back in 1 month
2. The patients who had undergone neck or shoulder surgery in 1 year
3. The patients with diagnosis as Fibromyalgia
4. The patients with diagnosis as Cervical radiculopathy or Myelopathy
5. Take blood-thinning medications including warfarin (Coumadin), or diagnosis as bleeding tendency disorder
6. History of Using Vitamin B in last 1 month
7. The Patients with intellectual or communication disabilities
8. Allergy to Lidocaine or Vitamin B
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical of muscle pain 4 weeks Numeric rating scale
- Secondary Outcome Measures
Name Time Method eck range of motion 4 weeks Goniometer,Quality of life 4 weeks Neck disability form